HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $202,000 | -1.0% | 1,834 | +6.8% | 0.01% | -12.5% |
| Q4 2020 | $204,000 | -12.1% | 1,718 | -33.5% | 0.02% | -27.3% |
| Q2 2020 | $232,000 | -68.6% | 2,585 | -64.9% | 0.02% | -65.1% |
| Q4 2018 | $738,000 | -24.7% | 7,372 | -21.5% | 0.06% | -20.3% |
| Q3 2018 | $980,000 | -39.0% | 9,387 | -47.6% | 0.08% | -31.9% |
| Q2 2018 | $1,606,000 | +102.3% | 17,916 | +65.0% | 0.12% | +118.9% |
| Q1 2018 | $794,000 | +25.6% | 10,856 | -0.3% | 0.05% | +29.3% |
| Q4 2017 | $632,000 | +29.2% | 10,888 | 0.0% | 0.04% | +24.2% |
| Q3 2017 | $489,000 | +13.2% | 10,888 | -0.4% | 0.03% | +10.0% |
| Q2 2017 | $432,000 | -23.9% | 10,929 | -22.0% | 0.03% | -23.1% |
| Q1 2017 | $568,000 | -99.9% | 14,010 | +2.8% | 0.04% | -35.0% |
| Q4 2016 | $548,000,000 | – | 13,622 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |